EP1717234A1 — Phenoxypropylpiperidines and -pyrrolidines and their use as histamine H3-receptor ligands
Assigned to Bioprojet SC · Expires 2006-11-02 · 20y expired
What this patent protects
The present patent application concerns compounds of formula (I), with R 1 and R 2 taken together with the nitrogen atom to which they are attached, form a mono or bicyclic saturated nitrogen-containing ring; their preparation and their use as a H3 receptor ligand for tre…
USPTO Abstract
The present patent application concerns compounds of formula (I), with R 1 and R 2 taken together with the nitrogen atom to which they are attached, form a mono or bicyclic saturated nitrogen-containing ring; their preparation and their use as a H3 receptor ligand for treating e.g. CNS disorders like Alzheimer's disease.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.